China Universal Asset Management »

Iovance Biotherapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $796k 54k 14.82
2023-12-31 $241k 30k 8.14
2023-09-30 $29k 6.4k 4.56
2023-06-30 $21k 2.9k 7.14
2023-03-31 $19k 3.0k 6.25
2022-12-31 $10k 1.6k 6.24
2022-09-30 $14k 1.5k 9.47

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Iovance Biotherapeutics

Vanguard Group
MHR Fund Management
Perceptive Advisors
venBio Select Advisor
Artisan Partners Limited Partnership
OrbiMed Advisors
Susquehanna International
Balyasny Asset Management
Goldman Sachs Group
Dimensional Fund Advisors
T. Rowe Price Associates
Jpmorgan Chase & Co
Credit Suisse
Long Focus Capital Management
Palo Alto Investors

View all funds holding Iovance Biotherapeutics